menu search

DCGO / DocGo: A Growth Stock Going Higher In 2023

DocGo: A Growth Stock Going Higher In 2023
DocGo Inc (NASDAQ: DCGO) has emerged as a buyable growth stock for 2023, which is saying something. The fallout from SVB's collapse is yet to be felt and will impact growth names this year. Read More
Posted: Mar 14 2023, 09:02
Author Name: MarketBeat
Views: 111536

DCGO News  

Why DocGo Stock Plummeted by 7% on Monday

By The Motley Fool
September 18, 2023

Why DocGo Stock Plummeted by 7% on Monday

Its CEO resigned abruptly. His official bio stated falsely that he earned a master's degree in artificial intelligence (AI). more_horizontal

DocGo Inc. (DCGO) Moves 6.8% Higher: Will This Strength Last?

By Zacks Investment Research
September 15, 2023

DocGo Inc. (DCGO) Moves 6.8% Higher: Will This Strength Last?

DocGo Inc. (DCGO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the s more_horizontal

DocGo: Preventing Onboarding Problem From Turning Into A Crisis (Rating Downgrade)

By Seeking Alpha
September 11, 2023

DocGo: Preventing Onboarding Problem From Turning Into A Crisis (Rating Downgrade)

DocGo was rewarded a no-bid contract by the NYC to provide medical care for the migrants, but this large contract is facing the risk of being revoked more_horizontal

Why Shares of DocGo Are Slumping Wednesday

By The Motley Fool
September 6, 2023

Why Shares of DocGo Are Slumping Wednesday

DocGo improved revenue in the second quarter. The company has added major contracts this year with EmblemHealth and Carnival Cruise Lines. more_horizontal

DocGo Inc. (DCGO) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 7, 2023

DocGo Inc. (DCGO) Q2 2023 Earnings Call Transcript

DocGo Inc. (NASDAQ:DCGO ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Corporate Participants Mike Cole - Director-Investor Relations An more_horizontal

DocGo Inc. (DCGO) Reports Q2 Loss, Tops Revenue Estimates

By Zacks Investment Research
August 7, 2023

DocGo Inc. (DCGO) Reports Q2 Loss, Tops Revenue Estimates

DocGo Inc. (DCGO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.07 p more_horizontal

DocGo Inc. (DCGO) Surges 5.0%: Is This an Indication of Further Gains?

By Zacks Investment Research
June 22, 2023

DocGo Inc. (DCGO) Surges 5.0%: Is This an Indication of Further Gains?

DocGo Inc. (DCGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for th more_horizontal

DocGo's growth story keeps building, analysts say after mixed 1Q results

By Proactive Investors
May 12, 2023

DocGo's growth story keeps building, analysts say after mixed 1Q results

DocGo delivered what analysts at Canaccord called “mixed” results, but that was enough for the firm to reiterate its Buy rating and $13 price targ more_horizontal


Search within

Pages Search Results: